tirzepatide ad Weight Loss Marketing Campaign Tirzepatide, Weight Loss Flyer, Weight

Description

GLP-1 medications like semaglutide (Ozempic and Wegovy) are often around weight loss, but the science on long-term health changed my mind.

This product is not intended to treat, mitigate, diagnose or cure any disease

Relieves occasional constipation (irregularity) Active ingredient: docusate sodium as a stomach softener laxative Gentle, reliable and stimulating free Produces intestinal movement within 12 to 72 hours Compare Colace feces with softener active ingredient Recommended for adults and children ages 2 and up

Group one included patients with moderate PAD who were started on GLP-1 RAs, and group two included patients with moderate PAD who were not started on GLP-1 RAs. At one year, patients with moderate PAD who were started on GLP-1 RAs had fewer major adverse limb events (MALE) (0.8% vs 1.5%), major adverse cardiac events (MACE) (25.4% vs 29.3%), and decreased risk of hospitalizations (17.9 vs 26.8%)